Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies

by Hans Frykman, Hans Frykman, Pankaj Kumar, Joel Oger, Joel Oger
Published 2020-12-01

When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?

by Mona Alkhawajah, Joel Oger
Published 2011-01-01

Review: Escalating immunotherapy of multiple sclerosis

by Peter Rieckmann, Anthony Traboulsee, Virginia Devonshire, Joel Oger
Published 2008-11-01

Modelling disease progression in relapsing–remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated...

by Kate Tilling, Michael Lawton, Neil Robertson, Helen Tremlett, Feng Zhu, Katharine Harding, Joel Oger, Yoav Ben-Shlomo
Published 2016-10-01

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

by Afsaneh Shirani, Yinshan Zhao, John Petkau, Paul Gustafson, Mohammad Ehsanul Karim, Charity Evans, Elaine Kingwell, Mia L. van der Kop, Joel Oger, Helen Tremlett
Published 2015-01-01

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

by Joel Oger, Joshua D Green, Bryan J Traynor, Richard J Barohn, Michael Benatar, Emanuela Bartoccion, Derrick Blackmore, Manisha Chopra, Andrea Corse, Mazen M Dimachkie, Amelia Evoli, Julaine Florence, Miriam Freimer, James F Howard, Theresa Jiwa, Henry J Kaminski, John T Kissel, Wilma J Koopman, Bernadette Lipscomb, Michelanglo Maestri, Mariapaola Marino, Janice M Massey, April McVey, Michelle M Mezei, Michael W Nicolle, Robert M Pascuzzi, Mamatha Pasnoor, Alan Pestronk, Carlo Provenzano, Roberta Ricciardi, David P Richman, Julie Rowin, Donald B Sanders, Zaeem Siddiqi, Aimee Soloway, Gil I Wolfe, Charlie Wulf, Daniel B Drachman
Published 2020-09-01